CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Daly James M Director | Grant or award · Director Stock Options (Right to Buy) | +14,368 | 14,368 | ||
| 2022-06-07 | Daly James M Director | Grant or award · Restricted Stock Units | +8,552 | 8,552 | ||
| 2022-06-07 | HARRIGAN EDMUND Director | Grant or award · Director Stock Options (Right to Buy) | +14,368 | 14,368 | ||
| 2022-06-07 | HARRIGAN EDMUND Director | Grant or award · Restricted Stock Units | +8,552 | 8,552 | ||
| 2022-06-07 | SOLAND DANIEL B Director | Grant or award · Director Stock Options (Right to Buy) | +14,368 | 14,368 | ||
| 2022-06-07 | SOLAND DANIEL B Director | Grant or award · Restricted Stock Units | +8,552 | 8,552 | ||
| 2022-06-07 | Brege Laura Director | Grant or award · Director Stock Options (Right to Buy) | +14,368 | 14,368 | ||
| 2022-06-07 | Brege Laura Director | Grant or award · Restricted Stock Units | +8,552 | 8,552 | ||
| 2022-06-07 | BAKER BROS. ADVISORS LP Director | Grant or award | +17,104 | 3,506,613 | ||
| 2022-06-07 | BAKER BROS. ADVISORS LP Director | Grant or award | +17,104 | 38,469,981 | ||
| 2022-06-07 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +28,736 | 28,736 | ||
| 2022-05-02 | DAVIS STEPHEN CEO | Sale | −5,483 | $18.18 | $100K | 75,875 |
| 2022-05-02 | Stankovic Srdjan R. President | Sale | −2,865 | $18.18 | $52K | 55,188 |
| 2022-05-02 | KIM AUSTIN D. EVP,General Counsel, Secretary | Sale | −894 | $18.18 | $16K | 16,742 |
| 2022-05-02 | Teehan Brendan EVP, COO, Head of Commercial | Sale | −552 | $18.18 | $10K | 3,437 |
| 2022-04-29 | DAVIS STEPHEN CEO | Option exercise | +15,625 | 81,358 | ||
| 2022-04-29 | DAVIS STEPHEN CEO | Option exercise · Restricted Stock Units | −15,625 | 15,625 | ||
| 2022-04-29 | Stankovic Srdjan R. President | Option exercise | +9,616 | 58,053 | ||
| 2022-04-29 | Stankovic Srdjan R. President | Option exercise · Restricted Stock Units | −9,616 | 9,616 | ||
| 2022-04-29 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise | +3,005 | 17,636 |
Page 26 of 63 · 1,260 trades